Literature DB >> 33745114

Visual Dysfunction in Multiple Sclerosis and its Animal Model, Experimental Autoimmune Encephalomyelitis: a Review.

Taekyun Shin1, Meejung Ahn2, Jeongtae Kim3, Kyungsook Jung4, Changjong Moon5, Moon-Doo Kim6.   

Abstract

Visual disabilities in central nervous system autoimmune diseases such as multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), are important symptoms. Past studies have focused on neuro-inflammatory changes and demyelination in the white matter of the brain and spinal cord. In MS, neuro-inflammatory lesions have been diagnosed in the visual pathway; the lesions may perturb visual function. Similarly, neuropathological changes in the retina and optic nerves have been found in animals with chronic EAE. Although the retina and optic nerves are immunologically privileged sites via the blood-retina barrier and blood-brain barrier, respectively, inflammation can occur via other routes, such as the uvea (e.g., iris and choroid) and cerebrospinal fluid in the meninges. This review primarily addresses the direct involvement of the blood-retina barrier and the blood-brain barrier in the development of retinitis and optic neuritis in EAE models. Additional routes, including pro-inflammatory mediator-filled choroidal and subarachnoid spaces, are also discussed with respect to their roles in EAE-induced visual disability and as analogues of MS in humans.

Entities:  

Keywords:  Demyelination; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Optic neuritis; Retinitis

Mesh:

Year:  2021        PMID: 33745114     DOI: 10.1007/s12035-021-02355-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  69 in total

Review 1.  Clinical assessment, management, and rehabilitation of walking impairment in MS: an expert review.

Authors:  Bernardita Soler; Cintia Ramari; Maxime Valet; Ulrik Dalgas; Peter Feys
Journal:  Expert Rev Neurother       Date:  2020-08-09       Impact factor: 4.618

Review 2.  The meninges as barriers and facilitators for the movement of fluid, cells and pathogens related to the rodent and human CNS.

Authors:  Roy O Weller; Matthew M Sharp; Myron Christodoulides; Roxana O Carare; Kjeld Møllgård
Journal:  Acta Neuropathol       Date:  2018-01-24       Impact factor: 17.088

3.  Neuroaxonal Degeneration in Patients With Multiple Sclerosis: An Optical Coherence Tomography and in Vivo Corneal Confocal Microscopy Study.

Authors:  Valeria Testa; Nicole De Santis; Riccardo Scotto; Carlo E Pastorino; Maria Cellerino; Sara Olivari; Alessia Jenny Morlacchi; Matilde Inglese; Antonio Uccelli; Carlo E Traverso; Michele Iester
Journal:  Cornea       Date:  2020-10       Impact factor: 2.651

4.  Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.

Authors:  Elena Garcia-Martin; Diego Rodriguez-Mena; Raquel Herrero; Carmen Almarcegui; Isabel Dolz; Jesus Martin; Jose R Ara; Jose M Larrosa; Vicente Polo; Javier Fernández; Luis E Pablo
Journal:  Neurology       Date:  2013-05-24       Impact factor: 9.910

5.  Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis.

Authors:  Elizabeth Gray; Taya L Thomas; Samar Betmouni; Neil Scolding; Seth Love
Journal:  Brain Pathol       Date:  2007-11-27       Impact factor: 6.508

Review 6.  Retinal and optic nerve diseases.

Authors:  Eyal Margalit; Srinivas R Sadda
Journal:  Artif Organs       Date:  2003-11       Impact factor: 3.094

7.  Focal thinning of the cerebral cortex in multiple sclerosis.

Authors:  Michael Sailer; Bruce Fischl; David Salat; Claus Tempelmann; Mircea Ariel Schönfeld; Evelina Busa; Nils Bodammer; Hans-Jochen Heinze; Anders Dale
Journal:  Brain       Date:  2003-06-04       Impact factor: 13.501

8.  The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis.

Authors:  T Shin; T Kojima; N Tanuma; Y Ishihara; Y Matsumoto
Journal:  J Neuroimmunol       Date:  1995-02       Impact factor: 3.478

9.  Subpial demyelination in the cerebral cortex of multiple sclerosis patients.

Authors:  Lars Bø; Christian A Vedeler; Harald I Nyland; Bruce D Trapp; Sverre J Mørk
Journal:  J Neuropathol Exp Neurol       Date:  2003-07       Impact factor: 3.685

10.  Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis.

Authors:  Praveena Manogaran; Marijana Samardzija; Anaïs Nura Schad; Carla Andrea Wicki; Christine Walker-Egger; Markus Rudin; Christian Grimm; Sven Schippling
Journal:  Acta Neuropathol Commun       Date:  2019-07-17       Impact factor: 7.801

View more
  1 in total

Review 1.  Emerging concepts in the treatment of optic neuritis: mesenchymal stem cell-derived extracellular vesicles.

Authors:  Anagha Aneesh; Alice Liu; Biji Mathew; Steven Roth; Heather E Moss; Douglas Feinstein; Sriram Ravindran
Journal:  Stem Cell Res Ther       Date:  2021-12-04       Impact factor: 8.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.